Max Healthcare Institute Q2 FY27 Results: Trend and Valuation

Max Healthcare Institute Q2 results (Sep26) are due. Q1 FY27 revenue Rs2,366 crore, OPM 25.27%, PAT Rs323 crore. CMP Rs1,061.3, PE 68.47x, ROE 14.7%.

Max Healthcare Institute Q2 results for the September 2026 quarter are the next major update for this hospital chain’s shareholders. Track the latest Max Healthcare Institute Ltd. share price on Univest as the company approaches its Q2 FY27 announcement. This Max Healthcare Institute Q2 results preview is based strictly on already-reported historical numbers, not on any forecast for the September quarter.

Max Healthcare Institute Q2 Results Date

No official Max Healthcare Institute Q2 results date has been announced yet. Hospital and healthcare companies in India typically report their September-quarter numbers in the October to November window, and Max Healthcare Institute Q2 results are expected to follow that same broad calendar once the board confirms a date. Investors should check the company’s own exchange filings for the confirmed Max Healthcare Institute Q2 results date.

Max Healthcare Institute Q2 Results Expectations

Max Healthcare Institute Q2 results expectations should be framed around the operational metrics and trend already on record, rather than any specific revenue or profit forecast. Revenue has grown steadily across the last five quarters, from Rs2,028 crore in Jun25 to Rs2,366 crore in Jun26, and operating margin has stayed in a relatively tight 25.27% to 28.28% band over that period. That consistency is the main reference point for Max Healthcare Institute Q2 results expectations. One historical item worth flagging is that the Sep25 quarter’s net profit of Rs491 crore was disproportionately high relative to its operating profit of Rs575 crore, which the company’s own screener note attributes to a negative effective tax rate one-off, a tax credit or reversal, so that particular quarter is not representative of the normal relationship between operating profit and net profit at Max Healthcare Institute, a nuance worth carrying into any reading of Max Healthcare Institute Q2 results.

Also read – Dabur India Q2 Results FY27 Preview

Max Healthcare Institute Q2 Results Preview: Previous Quarter (Q1 FY27, Jun26)

The quarter immediately before Max Healthcare Institute Q2 results, Q1 FY27 ended June 2026, is the most recent confirmed data point. Max Healthcare Institute reported revenue of Rs2,366 crore in Q1 FY27, its highest of the last five quarters, with operating profit of Rs598 crore, an operating margin of 25.27%, and net profit of Rs323 crore. This Jun26 print is the sequential base for Max Healthcare Institute Q2 results.

Q2 FY26 (Sep25): The Base Quarter for Comparison

Year-on-year comparisons for Max Healthcare Institute Q2 results will use the Q2 FY26 quarter ended September 2025 as the reference. In Sep25, Max Healthcare Institute reported revenue of Rs2,135 crore, operating profit of Rs575 crore, an operating margin of 26.93%, and net profit of Rs491 crore. As noted above, that Sep25 net profit figure was lifted by a negative effective tax rate one-off, so it is a less clean base for the profit line specifically when Max Healthcare Institute Q2 results are eventually compared year-on-year.

Recent Trend: Jun25 Through Jun26

The five-quarter trend ahead of Max Healthcare Institute Q2 results shows steady, incremental growth. Revenue moved from Rs2,028 crore in Jun25, to Rs2,135 crore in Sep25, Rs2,068 crore in Dec25, Rs2,143 crore in Mar26, and Rs2,366 crore in Jun26. Operating margin across the same five quarters read 25.79%, 26.93%, 26.02%, 28.28% and 25.27%, while net profit moved from Rs308 crore, to Rs491 crore, Rs301 crore, Rs342 crore, and Rs323 crore, with the Sep25 figure standing out because of the tax-related one-off already flagged. Excluding that one quarter’s tax effect, net profit has tracked operating profit fairly closely across the period, a pattern worth keeping in mind ahead of Max Healthcare Institute Q2 results. This is the fullest picture of trend data available before Max Healthcare Institute Q2 results are filed.

Key Factors to Watch Around Max Healthcare Institute Q2 Results

A few factors stand out for Max Healthcare Institute Q2 results. First, revenue growth has been consistent quarter after quarter, and whether that pace continues is a key marker for Max Healthcare Institute Q2 results. Second, operating margin has held in the 25% to 28% range across the last five quarters, so a reading meaningfully outside that band in Max Healthcare Institute Q2 results would be a departure from the recent pattern. Third, because Sep25’s net profit included a tax-related one-off, investors comparing Max Healthcare Institute Q2 results year-on-year should look at the operating profit line, not just net profit, to judge the underlying trend more cleanly.

Max Healthcare Institute Q2 Results: Valuation Snapshot

On valuation, Max Healthcare Institute trades at a CMP of Rs1,061.3, against a 52-week high of Rs1,221.9 and a 52-week low of Rs903.0. The trailing PE is 68.47x on an EPS of Rs15.5, price-to-book is 9.65x against a book value of Rs110.0, and return on equity is 14.7%. Debt-to-equity is low at 0.32, dividend yield is 0.19%, and market capitalisation is Rs1,02,537 crore, a large-cap base that itself has no bearing on the Max Healthcare Institute Q2 results outcome. The 50-day moving average is Rs1,046.45 and the 200-day moving average is Rs1,036.19, with an RSI of 74.94. These valuation figures stay on a trailing basis until Max Healthcare Institute Q2 results are formally reported.

Also read – Dalmia Bharat Q2 Results FY27 Preview

What to Watch When Max Healthcare Institute Q2 Results Are Announced

When Max Healthcare Institute Q2 results are announced, the key checks are revenue growth against the Rs2,366 crore Q1 FY27 base and the Rs2,135 crore Sep25 base, operating margin relative to the 25.27% to 28.28% band seen over the last five quarters, and whether net profit tracks operating profit in a normal way, given that Sep25’s net profit was lifted by a tax-related one-off that will not recur in every comparison involving Max Healthcare Institute Q2 results.

Want to follow Max Healthcare Institute through results season? Open a free Univest demat account to track the stock as new quarters are reported.

Conclusion

Max Healthcare Institute Q2 results for the September 2026 quarter have not yet been reported, and no date or figure should be treated as confirmed. The historical data through Jun26 shows a hospital business with steadily rising revenue and an operating margin that has stayed in a fairly tight 25% to 28% band, with one quarter’s net profit, Sep25, distorted upward by a tax-related one-off. That distinction is worth keeping in mind while awaiting Max Healthcare Institute Q2 results.

Ready to track Max Healthcare Institute ahead of its Q2 FY27 print? Open your Univest demat account here.

Follow the healthcare sector alongside Max Healthcare Institute by choosing to open a demat account with Univest today.

This article is for informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Data points cited are drawn from historical, already-reported financial results and publicly available market data, and figures for the Q2 FY27 (September 2026) quarter had not been announced as of the date of writing. Investments in securities are subject to market risk; please read all scheme and company-related documents carefully and consult a SEBI-registered investment or research advisor before making any investment decision. Univest Research Services is a SEBI-registered Research Analyst, registration number INH000013776.

When will Max Healthcare Institute Q2 results be announced?

Ans. No official Max Healthcare Institute Q2 results date has been announced yet. Hospital and healthcare companies in India typically report their September-quarter numbers in the October to November window, and Max Healthcare Institute is expected to follow that same broad calendar.

What was Max Healthcare Institute’s performance in Q1 FY27?

Ans. In Q1 FY27 (Jun26), Max Healthcare Institute reported revenue of Rs2,366 crore, operating profit of Rs598 crore, an operating margin of 25.27%, and net profit of Rs323 crore.

Why was Max Healthcare Institute’s Sep25 net profit unusually high?

Ans. In the Sep25 quarter, net profit of Rs491 crore was disproportionately high relative to operating profit of Rs575 crore because of a negative effective tax rate one-off, a tax credit or reversal, according to the company’s own screener note.

What is Max Healthcare Institute’s valuation ahead of Q2 results?

Ans. Max Healthcare Institute trades at a CMP of Rs1,061.3, a trailing PE of 68.47x on an EPS of Rs15.5, a price-to-book of 9.65x, and a return on equity of 14.7%, with a market capitalisation of Rs1,02,537 crore.